Calcium channel blocker amlodipine besylate is associated with reduced case fatality rate of COVID-19 patients with hypertension

Lei-Ke Zhang, Yuan Sun, Haolong Zeng, Yudong Peng, Xiaming Jiang, Wei-Juan Shang, Yan Wu, Shufen Li, Yu-Lan Zhang, Liu Yang, Hongbo Chen, Runming Jin, Wei Liu, Hao Li, Ke Peng, Gengfu Xiao
doi: https://doi.org/10.1101/2020.04.08.20047134

Article usage

Article usage: April 2020 to November 2024

AbstractFullPdf
Apr 2020733902578
May 202046810814
Jun 202019820349
Jul 202021680332
Aug 202015410562
Sep 202010520206
Oct 20209380473
Nov 2020183019249
Dec 202013618148
Jan 20217442100
Feb 2021447786
Mar 2021374566
Apr 202139720104
May 2021298993
Jun 2021222951
Jul 2021195742
Aug 20212111335
Sep 2021187531
Oct 2021141446
Nov 2021141547
Dec 2021148416
Jan 2022176919
Feb 20221381022
Mar 2022103548
Apr 2022791241
May 2022114231
Jun 202286212
Jul 202264510
Aug 2022641119
Sep 202266421
Oct 202279721
Nov 202295510
Dec 202285411
Jan 2023641212
Feb 202367107
Mar 202355109
Apr 202332715
May 2023141112
Jun 202318177
Jul 20231527
Aug 2023681713
Sep 2023311517
Oct 202331317
Nov 2023532111
Dec 20231703
Jan 202414110
Feb 202415310
Mar 202428127
Apr 202420119
May 20241545
Jun 20242499
Jul 202432529
Aug 20242758
Sep 202425915
Oct 20241957
Nov 202417615
Back to top
Posted April 14, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Calcium channel blocker amlodipine besylate is associated with reduced case fatality rate of COVID-19 patients with hypertension
Lei-Ke Zhang, Yuan Sun, Haolong Zeng, Yudong Peng, Xiaming Jiang, Wei-Juan Shang, Yan Wu, Shufen Li, Yu-Lan Zhang, Liu Yang, Hongbo Chen, Runming Jin, Wei Liu, Hao Li, Ke Peng, Gengfu Xiao
medRxiv 2020.04.08.20047134; doi: https://doi.org/10.1101/2020.04.08.20047134
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area